Yahoo Web Search

  1. Yahoo Finance Results

  2. Keytruda sales power Merck to quarterly beat

    Reuters via Yahoo FinanceMay 01 15:58 PM

    Shares dropped 2.8 percent to $57.22, however, on investor concerns that the company is becoming increasingly reliant on the drug, which is positioned to become the leading player in a new generation ...

  3. Merck posts 52.5 percent fall in quarterly profit

    Reuters via Yahoo FinanceMay 01 10:51 AM

    Drugmaker Merck & Co posted a 52.5 percent fall in first-quarter profit on Tuesday, hurt by hefty charge related to its collaboration with Eisai Co Ltd. Net income ...

    73.37N/A (N/A%)

    at Fri, May 18, 2018, 14:50PM EST - U.S. Markets close in 4 hrs 49 mins

    Delayed Quote

    • Open 0.00
    • High 0.00
    • Low 0.00
    • Prev. Close 73.37
    • 52 Wk. High 0.00
    • 52 Wk. Low 0.00
    • P/E 77.39
    • Mkt. Cap 20.95B
  4. Merck reported a better-than-expected first-quarter profit. The drugmaker's profit was driven by a more than 150 percent rise in sales of Keytruda. Revenue from the cancer drug accounted for ...

  5. Web results

  6. Eisai Co., Ltd.


    Welcome to the Eisai Official Corporate Website Eisai Co., Ltd. Page.

  7. Stock analysis for Eisai Co Ltd (4523:Tokyo) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  8. About Eisai | Eisai Co., Ltd.

    Welcome to the Eisai Official Corporate Website About Eisai Page.

  9. ESALF Stock Price - Eisai Co. Ltd. Stock Quote (U.S.: OTC ...

    Eisai Co. Ltd. stock price, stock quotes and financial overviews from MarketWatch.

  10. Eisai (company) - Wikipedia

    Eisai Co., Ltd. (エーザイ株式会社, Ēzai Kabushiki-gaisha) is a Japanese pharmaceutical company headquartered in Tokyo, Japan.It has some 10,000 employees, among them about 1,500 in research.

  11. ESALY Profile | EISAI CO Stock - Yahoo Finance

    See the company profile for EISAI CO (ESALY) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their compensation.

  12. Eisai Co Ltd, 4523:TYO summary -

    Latest Eisai Co Ltd (4523:TYO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

  13. Eisai Co., Ltd. and Merck Enter Global Strategic Oncology ...

    Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as “giving ...

  14. About Eisai Inc. | Eisai Inc.

    About Eisai Inc. Eisai is a human ... Eisai Inc. is supported by a strong parent company, Eisai Co., Ltd., which was founded in Japan in 1941 as Nihon Eisai Co., Ltd ...

  15. Welcome to Eisai Inc. Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd, a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

  1. Ads
    related to EISAI, Co., Ltd